Among them, SUSTAIN-6 and PIONEER-6 were the cardiovascular outcome trials (CVOTs) that studied the primary adverse cardiovascular outcomes (nonfatal stroke, nonfatal myocardial infarction, or death from cardiovascular causes)
There's no aggressive tone, no shaming language, and no overpromising
The approval of semaglutide marked a significant advancement in the pharmacological approach to managing obesity and diabetes, two of the most pressing public health concerns of our time
Alongside liraglutide, semaglutide has been shown to effectively improve motor impairments, rescue tyrosine hydroxylase (TH) levels, reduce -synuclein accumulation, chronic inflammation response in the brain and lipid peroxidation, inhibit mitochondrial mitophagy signaling and protect dopaminergic neurons in the substantia nigra and striatum in MPTP mouse models of PD [81]
Wegovy is a GLP-1 receptor agonist designed for long-term metabolic regulation